Novo Nordisk slams Danish Medicines Council's methodology: Has flaws and shortcomings
![Kasper Bødker Mejlvang, general manager for Denmark and Iceland at Novo Nordisk | Photo: Novo Nordisk / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13765652.ece/ALTERNATES/schema-16_9/doc7juwydr4uczo13ptbbl.jpg)
A few weeks ago, Novo Nordisk expressed its discontent in a letter sent to the Danish Medicines Council over its treatment guidelines for type 2 diabetes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.